<DOC>
	<DOC>NCT01669291</DOC>
	<brief_summary>The purpose of this study is to determine if utilizing GnRH antagonists versus agonist long protocol during controlled ovarian stimulation (COH) with human-derived gonadotropins for assisted reproduction affects IVF outcome, peak estradiol level, and duration of stimulation.</brief_summary>
	<brief_title>Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation</brief_title>
	<detailed_description>No detailed description</detailed_description>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Ages 2140 (inclusive up to 41) Day 24 FSH &lt; or equal to 10 Antimullerian Hormone (AMH) greater than or equal to 1.0 Between 5 and 20 antral follicles on day 24 Body Mass Index (BMI)&gt;or equal to 18 and &lt; or equal to 32 Smokers Polycystic Ovarian Disease Endometriosis greater than Stage I Testicular aspirated sperm</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>